Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Devenlafaxine 50mg Extended Release Tablets
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹105/-
Denexine OD 50 Tablet contains Desvenlafaxine 50mg in an extended-release formulation. Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that enhances the levels of these neurotransmitters in the brain, helping to stabilize mood and alleviate symptoms of depression. The extended-release nature ensures a steady release of the medicine throughout the day, providing consistent therapeutic benefits and improving patient compliance. It is commonly prescribed in the management of mood disorders and emotional imbalance.
Common side effects may include nausea, dry mouth, dizziness, decreased appetite, constipation, and sweating. Some patients may experience increased blood pressure, insomnia, or sexual dysfunction. Most side effects are mild and temporary, but medical attention should be sought if they persist or worsen.
Denexine OD 50 is primarily indicated for the treatment of major depressive disorder (MDD) in adults. It helps reduce symptoms such as persistent sadness, anxiety, irritability, fatigue, changes in sleep and appetite, and lack of interest in daily activities. It may also be used in other related psychiatric conditions based on a physician’s assessment.
Use Denexine OD 50 only as prescribed by a healthcare professional. Do not stop the medication abruptly, as it may lead to withdrawal symptoms. Caution is advised in patients with hypertension, liver or kidney disease, and those taking other psychiatric medications. Avoid alcohol consumption during therapy.
Store in a cool, dry place between 2°C to 8°C. Protect from light. Reconstitute with sterile water for injection as directed and use immediately after preparation. Keep out of reach of children.
Composition : Levofloxacin 500mg Infusion
Composition : Moxifloxacin IP 400 mg + Mannitol IP 5.0% w/v Infusuion
Composition : Azithromycin (500mg) Injection
Composition : Cefuroxime (1.5gm)
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
Composition : Clarithromycin (500mg) Injection
Composition : Colistimethate Sodium (2Million IU)
Composition : Colistimethate Sodium (1Million IU)
Composition : Ceftazidime (1gm)
Composition : Ceftazidime (250mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation